Sharing a few threads on whether molnupiravir (new antiviral on the cusp of approval) risks generating new variants because the mutations it induces may, rarely but possibly, not kill the virus but generate viable variants instead. Many on the FDA panel who voted no raised this.https://twitter.com/CT_Bergstrom/status/1467611446053851145 …
-
Show this thread
-
Replying to @zeynep
This is potentially a very significant problem. Any thoughts on what inducing random mutations into RNA does to your own proteins or even DNA if it happens during copying? Along with the relatively low efficacy, it seems like this is much less of a no-brainer than Paxlovid
1 reply 0 retweets 1 like
Replying to @OriginalAlpaca
The big concern about the virus RNA, not your DNA.
9:41 AM - 6 Dec 2021
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.